Advertisement

Depolarization Induced Hydrolysis of Cytoplasmic ACh in Mouse Brain

  • P. T. Carroll
Part of the Advances in Behavioral Biology book series (ABBI, volume 30)

Abstract

Acetylcholine (ACh) release occurs from cholinergic nerve endings in brain by different processes. Spontaneous ACh release, for example, appears to occur primarily from the cytosol by a Ca2+ independent process (5–7) and may be synthesized by a soluble, cytoplasmic form of choline-O-acetyltransferase (EC 2.3.1.6, ChAT) (3). In contrast, the evoked form of ACh release appears to occur from a vesicular fraction by a Ca2+ dependent process (6–9, 18) and it may be synthesized by a membrane-bound form of ChAT closely associated with the vesicular fraction (1–3, 17). Recent reports suggest that the Ca2+ dependent and Ca2+ independent forms of ACh release differ in yet another respect. Depolarization of brain tissue only stimulates the Ca2+ dependent, not the Ca2+ independent form of ACh release (9, 13–14). That depolarization of brain tissue is unable to stimulate the Ca2+ independent release of ACh is difficult to reconcile with the finding that high K+ induced depolarization of brain tissue not only lowers the ACh content of the vesicular fraction but also lowers the ACh content of the cytoplasmic fraction (16). One might expect that elevated K+ would exclusively lower the level of vesicular ACh since it only stimulates the Ca2+ dependent form of ACh release. One possible explanation for the K+ induced reduction of cytoplasmic ACh in the absence of a corresponding stimulation of Ca2+ independent ACh release is that high K+ may cause the hydrolysis of cytoplasmic ACh and thereby lower its level.

Keywords

AChE Inhibitor Subcellular Level Independent Form Cytoplasmic Pool Mouse Forebrain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Badamchian, M. and Carroll, P.T.: J. Neurosci. (in press).Google Scholar
  2. 2.
    Benishin, C.G. and Carroll, P.T. (1981): J. Neurochem. 36: 732–740.CrossRefGoogle Scholar
  3. 3.
    Benishin, C.G. and Carroll, P.T. (1983): J. Neurochem. 41: 1030–1039.CrossRefGoogle Scholar
  4. 4.
    Benishin, C.G. and Carroll, P.T. (1984): J. Neurochem. 43: 885–887.CrossRefGoogle Scholar
  5. 5.
    Carroll, P.T. (1983): Neurochem. Res. 8: 1271–1283.CrossRefGoogle Scholar
  6. 6.
    Carroll, P.T. (1984): Brain Res. 321: 55–62.CrossRefGoogle Scholar
  7. 7.
    Carroll, P.T. and Aspry, J.M. (1980): Science 210: 641–642.CrossRefGoogle Scholar
  8. 8.
    Carroll, P.T. and Aspry, J.M. (1981): Neuroscience 6: 2555–2559.CrossRefGoogle Scholar
  9. 9.
    Carroll, P.T. and Benishin, C.G. (1984): Brain Res. 291: 261–272.CrossRefGoogle Scholar
  10. 10.
    Carroll, P.T. and Goldberg, A.M. (1975): J. Neurochem. 25: 523–527.CrossRefGoogle Scholar
  11. 11.
    Carroll, P.T. and Nelson, S.H. (1978): Science 199: 85–86.CrossRefGoogle Scholar
  12. 12.
    Collier, B., Poon, P. and Salehmoghaddam, S. (1972): J. Neurochem. 51–60.Google Scholar
  13. 13.
    Gibson, G.E. and Peterson, C. (1981): J. Neurochem. 978–984.Google Scholar
  14. 14.
    Meyer, E.M. and Cooper, J.R. (1981): J. Neurochem. 37:1186–1192.Google Scholar
  15. 15.
    Nelson, S.H., Benishin, C.G. and Carroll, P.T. (1980): Biochem. Pharmacol. 29: 1949–1957.CrossRefGoogle Scholar
  16. 16.
    Salehmoghaddam, S.H. and Collier, B. (1976): J. Neurochem. 27: 71–76.CrossRefGoogle Scholar
  17. 17.
    Smith, C.P. and Carroll, P.T. (1980): Brain Res. 185: 363–371.CrossRefGoogle Scholar
  18. 18.
    Suszkiw, J.B. and O’Leary, M.E. (1982): J. Neurochem. 38: 1668–1675.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • P. T. Carroll
    • 1
  1. 1.Department of PharmacologyTexas Tech University Health Sciences CenterLubbockUSA

Personalised recommendations